{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:39:34Z","timestamp":1773290374305,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2000,2]]},"DOI":"10.1023\/a:1009693811093","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T22:47:08Z","timestamp":1040597228000},"page":"79-85","source":"Crossref","is-referenced-by-count":17,"title":["In vitro evaluation of GL331's cancer cell killing and apoptosis-inducing activity in combination with other chemotherapeutic agents"],"prefix":"10.1007","volume":"5","author":[{"given":"Tze-Sing","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hung","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Chung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Tzong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Whang-Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"254274_CR1","unstructured":"Whang-Peng J, HuangT-S.Newtrials of GL331, a novel topoisomerase II inhibitor, in treatment of solid tumors. J Intern Med\n84."},{"key":"254274_CR2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0304-3835(96)04464-3","volume":"110","author":"T-S Huang","year":"1996","unstructured":"Huang T-S, Shu C-H, Shih Y-L, et al. J. Protein tyrosine phosphatase activities are involved in apoptotic cancer cell death induced by GL331, a new homolog of etoposide. Cancer Lett 1996; 110: 77\u201385.","journal-title":"Cancer Lett"},{"key":"254274_CR3","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1023\/A:1018971313256","volume":"16","author":"T-S Huang","year":"1999","unstructured":"Huang T-S, Lee C-C, Chao Y, et al. A novel podophyllotoxinderived compound GL331 is more potent than its congener VP-16 in killing refractory cancer cells. Pharmaceut Res 1999; 16: 997\u20131002.","journal-title":"Pharmaceut Res"},{"key":"254274_CR4","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1038\/sj.onc.1202133","volume":"17","author":"M-L Kuo","year":"1998","unstructured":"Kuo M-L, Shen S-C, Yang C-H, Chuang S-E, Cheng A-L, Huang T-S. Bcl-2 prevents topoisomerase II inhibitor GL331\u2013induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity. Oncogene 1998; 17: 2225\u20132234.","journal-title":"Oncogene"},{"key":"254274_CR5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF01321105","volume":"1","author":"T-S Huang","year":"1996","unstructured":"Huang T-S, Yang WK, Whang-Peng J. GL331\u2013induced disruption of cyclin B1\/CDC 2 complex and inhibition of CDC 2 kinase activity. Apoptosis 1996; 1: 213\u2013217.","journal-title":"Apoptosis"},{"key":"254274_CR6","first-page":"2974","volume":"57","author":"T-S Huang","year":"1997","unstructured":"Huang T-S, Shu C-H, Yang WK, Whang-Peng J. Activation of CDC 25 phosphatase and CDC 2 kinase involved in GL331\u2013induced apoptosis. Cancer Res 1997; 57: 2974\u20132978.","journal-title":"Cancer Res"},{"key":"254274_CR7","first-page":"281","volume-title":"Resistance to Antineoplastic Drugs","author":"DM Sullivan","year":"1989","unstructured":"Sullivan DM, Chow K-C, Ross WE. Topoisomerase II mediated mechanisms of drug resistance. In: Kessel D, ed. Resistance to Antineoplastic Drugs. Boca Raton, FL: CRC Press, 1989: 281\u2013292."},{"key":"254274_CR8","first-page":"716","volume":"68","author":"C-T Lin","year":"1993","unstructured":"Lin C-T, Chan W-Y, Chen W, et al. Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lab Invest 1993; 68: 716\u2013727.","journal-title":"Lab Invest"},{"key":"254274_CR9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF01321020","volume":"1","author":"C-H Shu","year":"1996","unstructured":"Shu C-H, Yang WK, Huang T-S. Increased cyclin B1\/CDC 2 kinase activity and phosphorylation of Bcl-2 associated with paclitaxel-induced apoptosis in human nasopharyngeal carcinoma cells. Apoptosis 1996; 1: 141\u2013146.","journal-title":"Apoptosis"},{"key":"254274_CR10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/A:1009649025439","volume":"3","author":"R Overbeeke","year":"1998","unstructured":"Overbeeke R, Steffens-Nakken H, Vermes I, Reutelingsperger C, Haanen C. Early features of apoptosis detected by four different flow cytometry assays. Apoptosis 1998; 3: 115\u2013121.","journal-title":"Apoptosis"},{"key":"254274_CR11","first-page":"625","volume":"13","author":"T-S Huang","year":"1996","unstructured":"Huang T-S, Kuo M-L, Shew J-Y, Chou Y-W, Yang WK. Distinct p53\u2013mediated G1\/S checkpoint responses in two NIH3T3 subclone cells following treatment with DNAdamaging agents. Oncogene 1996; 13: 625\u2013632.","journal-title":"Oncogene"},{"key":"254274_CR12","first-page":"90","volume-title":"The Chemotherapy Source Book","author":"ML. Friedland","year":"1992","unstructured":"Friedland ML. Combination chemotherapy. In: Perry MC, ed. The Chemotherapy Source Book. Baltimore, MD: Williams & Wilkins, 1992: 90\u201395."},{"key":"254274_CR13","first-page":"235","volume-title":"The Anticancer Drugs","author":"WB Pratt","year":"1994","unstructured":"Pratt WB, Ruddon RW, Ensminger WD, Maybaum J. Choice of drugs for cancer chemotherapy. In: The Anticancer Drugs. New York: Oxford University Press, 1994: 235\u2013246."}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1009693811093.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1009693811093\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1009693811093.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T16:04:10Z","timestamp":1747584250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1009693811093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["254274"],"URL":"https:\/\/doi.org\/10.1023\/a:1009693811093","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,2]]}}}